Estimated Glomerular Filtration Rate Variability in Patients with Diabetes Receiving SGLT2 Inhibitors Versus DPP4 Inhibitors

<b>Background:</b> Major clinical trials regarding sodium–glucose cotransporter 2 inhibitors (SGLT2is) have focused on estimated glomerular filtration rate (eGFR) slope and composite kidney outcomes, with limited evaluation of eGFR variability as a kidney outcome or its long-term implications in pat...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yi-Wei Kao, Tze-Fan Chao, Yu-Wen Cheng, Shao-Wei Chen, Yi-Hsin Chan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2025-10-01
Colecção:	Pharmaceutics
Assuntos:	eGFR variability sodium–glucose cotransporter 2 inhibitor dipeptidyl peptidase-4 inhibitor major adverse kidney event type 2 diabetes
Acesso em linha:	https://www.mdpi.com/1999-4923/17/11/1370
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!